Article · 9 Nov 2026
Conference abstract
Effects of anandamide and agmatine on cisplatin-induced neuropathy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: Cisplatin is a commonly used antineoplastic agent for the treatment of several solid tumors. Peripheral neuropathy is one of its major side effects. Agmatine has been shown to relieve neuropathic pain in different animal models. Cannabinoids have also shown analgesic features in neuropathic pain models. The aim of this study was to investigate the effects of anandamide, a cannabinoid receptor agonist and agmatine on cisplatin-induced neuropathy. Materials & Methods: Neuropathy was induced in male Wistar rats (250-300 gm, n=6) by intra-peritoneal injections of cisplatin (3 mg/kg once a week for five consecutive weeks). The development of neuropathy was evaluated using tests for both mechanical allodynia and heat-hypo/hyperalgesia. After 5 weeks of treatments, cardiac perfusion with para-formaldehyde was performed and Dorsal Root Ganglion (DRG) neurons were collected for further electron microscopic evaluation. Single dose of agmatine (100 mg/kg) or anandamide (1 mg/kg) was given intra-peritoneally. The development of neuropathy was evaluated using tests for both mechanical allodynia and heat-hypo/hyperalgesia. Spontaneous locomotor activity, rectal temperature, anti-nociception and catalepsy were evaluated for cannabinoid tetrad. After 5 weeks of treatments, cardiac perfusion with para-formaldehyde was performed and Dorsal Root Ganglion (DRG) neurons were collected for further electron microscopic evaluation. Results: Cisplatin treatment induced mechanical allodynia and thermal hyperalgesia. Single dose of agmatine significantly attenuated cisplatin-induced mechanical allodynia. Conclusions: It seems that agmatine may have anti-nociceptive activity on cisplatin-induced neuropathy. However, single dose of anandamide did not alleviate cisplatin-induced thermal hyperalgesia.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Pharmacology.
Article · 23 Feb 2026
A Thorough Overview of Polycystic Ovary Syndrome (PCOS) in Female Rats
Article · 19 Dec 2025
Theoretical Pharmacology: Understanding Drug Action Through Models and Principles
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Pharmacology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Kevser Erol”
- BylineArticles whose byline prints “Bilgin Kaygisiz”
- BylineArticles whose byline prints “Cigdem Cengelli”
- BylineArticles whose byline prints “Sule Aydin”
- BylineArticles whose byline prints “Basak Donertas”
- BylineArticles whose byline prints “Engin Yildirim”
- BylineArticles whose byline prints “Emel Ulupinar”
